Deptartment of Hematology and Oncology
Karin Schilbach has not added Biography.
If you are Karin Schilbach and would like to personalize this page please email our Author Liaison for assistance.
Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells.
Blood Feb, 2003 | Pubmed ID: 12393715
Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers.
Transplantation Jul, 2004 | Pubmed ID: 15257036
Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells.
The hematology journal : the official journal of the European Haematology Association / EHA , 2004 | Pubmed ID: 15297850
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
Blood Jul, 2005 | Pubmed ID: 15731181
Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Mar, 2005 | Pubmed ID: 15744238
Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation May, 2005 | Pubmed ID: 15846291
PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
Transplantation Jul, 2007 | Pubmed ID: 17667813
EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomas.
Brain pathology (Zurich, Switzerland) Apr, 2009 | Pubmed ID: 18489490
DNA quantification and fragmentation in sputum after inhalation of recombinant human deoxyribonuclease.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology , 2008 | Pubmed ID: 18769062
Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) Nov-Dec, 2008 | Pubmed ID: 18832998
Pre-differentiated human committed T-lymphoid progenitors promote peripheral T-cell re-constitution after stem cell transplantation in immunodeficient mice.
European journal of immunology Dec, 2011 | Pubmed ID: 21928276
miHA-Match: computational detection of tissue-specific minor histocompatibility antigens.
Journal of immunological methods Dec, 2012 | Pubmed ID: 22985828
T-helper-1-cell cytokines drive cancer into senescence.
Nature Feb, 2013 | Pubmed ID: 23376950
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival.
Pigment cell & melanoma research Jul, 2014 | Pubmed ID: 24703331
Human Peripheral CD4(+) Vδ1(+) γδT Cells Can Develop into αβT Cells.
Frontiers in immunology , 2014 | Pubmed ID: 25709606
Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells.
Glycobiology Aug, 2015 | Pubmed ID: 25978997
Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation.
Oncoimmunology Jul, 2015 | Pubmed ID: 26140238
Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.
Journal of autoimmunity Aug, 2015 | Pubmed ID: 26143958
Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo.
Annals of hematology Nov, 2015 | Pubmed ID: 26264693
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved